Screening assays and methods

US11154833B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11154833-B2
Application numberUS-201816170323-A
CountryUS
Kind codeB2
Filing dateOct 25, 2018
Priority dateSep 16, 2005
Publication dateOct 26, 2021
Grant dateOct 26, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Screening assays and methods of performing such assays are provided. In certain examples, the assays and methods may be designed to determine whether or not two or more species can associate with each other. In some examples, the assays and methods may be used to determine if a known antigen binds to an unknown monoclonal antibody.

First claim

Opening claim text (preview).

What is claimed: 1. An apparatus comprising a moldable slab in contact with a substrate, said moldable slab defining a plurality of wells, wherein each well has a side or diameter of less than 100 microns and contains not more than a single or a few cell(s), wherein at least one of said wells contains the respective single or few cell(s), said respective single or few cell(s) having produced one or more cell-derived product(s) in a volume no greater than about 10 nanoliters in each said well containing said respective single or few cell(s), said one or more cell-derived product(s) being bound to the substrate at a location in fluid communication with said respective well containing said respective single or few cell(s). 2. The apparatus of claim 1 , wherein each well has a diameter of 10 to 100 microns. 3. The apparatus of claim 2 , wherein each well has a diameter of 50 to 100 microns. 4. The apparatus of claim 1 , wherein the respective single or few cell(s) produce the cell-derived product in a volume of 100 picoliters to 1 nanoliter. 5. The apparatus of claim 1 , wherein the substrate is a glass substrate. 6. The apparatus of claim 1 , wherein the moldable slab comprises poly(dimethylsiloxane). 7. The apparatus of claim 1 , wherein the respective single or few cell(s) comprise(s) one or more members selected from the group consisting of a T cells, a B cells, a liver cells, and a kidney cells. 8. The apparatus of claim 1 , wherein the cell-derived product comprise(s) one or more members selected from the group consisting of a DNA, RNA, cytokine, chemokine, inflammatory mediator, monokine, lymphokine, a growth factor, a lipid, and a pathogen. 9. The apparatus of claim 1 , wherein the moldable slab is reversibly sealed to the substrate so as to form a substantially fluid tight seal. 10. The apparatus of claim 1 , wherein each well has a diameter of 10 to 100 microns; the respective single or few cell(s) produce the cell-derived product in a volume of 100 picoliters to 1 nanoliter; the substrate is a glass substrate; the moldable slab comprises poly(dimethylsiloxane); and the moldable slab is reversibly sealed to the substrate so as to form a substantially fluid tight seal. 11. The apparatus of claim 1 , wherein the substrate comprises a plastic material. 12. The apparatus of claim 1 , wherein the cell-derived product(s) is/are secreted. 13. The apparatus of claim 1 , wherein the cell-derived product(s) is/are liberated from the respective single or few cell(s) by lysis or permeabilization. 14. The apparatus of claim 1 , wherein the substrate has a capture ligand immobilized thereon for retaining at least one of the cell-derived product(s), wherein the capture ligand is an antigen, a protein or an antibody. 15. The apparatus of claim 1 , wherein the substrate has a substantially planar surface. 16. A method comprising temporarily confining cells in a plurality of wells using the apparatus of claim 1 , and selectively recovering the single or few cell(s) from an identified well, said well identified from the one or more cell-derived product(s) produced by said single or few cell(s) while temporarily confined in said well, said one or more cell-derived product(s) being bound to the substrate at a location having been in fluid communication with said well.

Assignees

Inventors

Classifications

  • Specific details about materials · CPC title

  • Specific details about manufacturing devices · CPC title

  • Align devices or objects to ensure defined positions relative to each other · CPC title

  • Microarrays; Biochips · CPC title

  • Peptides · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11154833B2 cover?
Screening assays and methods of performing such assays are provided. In certain examples, the assays and methods may be designed to determine whether or not two or more species can associate with each other. In some examples, the assays and methods may be used to determine if a known antigen binds to an unknown monoclonal antibody.
Who is the assignee on this patent?
Harvard College
What technology area does this patent fall under?
Primary CPC classification B01J19/0046. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Oct 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).